| DC Field | Value | Language |
|---|
| dc.contributor.author | Galenko-Yaroshevsky, P. A. | - |
| dc.contributor.author | Popkov, V. L. | - |
| dc.contributor.author | Bedrosova, K. A. | - |
| dc.contributor.author | Faustov, L. A. | - |
| dc.contributor.author | Sukoyan, G. V. | - |
| dc.date.accessioned | 2022-04-22T16:25:23Z | - |
| dc.date.available | 2022-04-22T16:25:23Z | - |
| dc.date.issued | 2019 | - |
| dc.identifier.citation | Benzofurocaine: effects on experimental periodontitis, anti-diabetic activity and molecular mechanisms of action / P.A. Galenko-Yaroshevsky [et al.] // Research Results in Pharmacology. - 2019. - Vol. 5, № 1.- P. 15-30. - Doi: 10.3897/rrpharmacology.5.33100. - Refer.: p. 28-29. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46301 | - |
| dc.description.abstract | A promising compound for the treatment of inflammatory periodontal diseases is benzofuracaine (BFC). BFC has pronounced anti-inflammatory, analgesic, reparative, hypoglycemic and other effects. Objective: To assess the influence of benzofuracaine on experimental periodontitis and to study its antidiabetic activity and molecular mechanisms of action | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | benzofurocaine | ru |
| dc.subject | periodontitis | ru |
| dc.subject | normoglycemia | ru |
| dc.subject | experimental diabetes mellitus | ru |
| dc.title | Benzofurocaine: effects on experimental periodontitis, anti-diabetic activity and molecular mechanisms of action | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 5, № 1
|
